亿胜生物科技（股票代码：01061）于2026年6月25日公告，基于回购授权在香港联交所场内回购合计10万股普通股，占该次事件前已发行股本（不包括库藏股）约0.01765%。每股回购价介乎港币2.63元至2.64元，合计支付约26.35万港元。回购完成后，公司已发行股本（不包括库藏股）变更为5.66333亿股，库藏股数增至67.3万股。
公司此前于2026年5月26日通过回购授权，总可回购股份数为5670.06万股。截至目前，公司已在交易所累积回购67.3万股，占授权通过日已发行股本的约0.11869%。公告同时确认已遵守相关上市规则与法例程序。
本公告由公司董事方海洲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.